Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502
- Citation:
- NPJ Breast Cancer vol 10
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub-ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 13
- Parents:
- 3970
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Breast
- Pharmas:
- Bristol-Meyers Squibb (Abraxis/Celgene).
- Grants:
- U10CA180821, U10CA180882, U24 CA196171, UG1CA233180, UG1CA233329, UG1CA233331, UG1CA233339, UG1CA233373
- Corr. Author:
- Authors:
- Daniel G. Stover Roberto Salgado Oleksander Savenkov Karla Ballman Erica L. Mayer Mark Jesus M. Magbanua Sherene Loi Mark Vater Kristyn Glover Mark Watson Yujia Wen W. Fraser Symmans Charles Perou Lisa A. Carey Ann H. Partridge Hope S. Rugo
- Networks:
- CA824, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-OH007, LAPS-TX035
- Study
- CALGB-40502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: